The Magnet

Clue: ALP and GGT are both markedly elevated while ALT/AST are only mildly up. That is a cholestatic pattern, not hepatocellular damage.

Bridge: Think of ALP and GGT as the "bile duct enzymes." When metastatic nodules compress intrahepatic bile ducts, biliary flow backs up and these enzymes spill into the blood, even before the patient turns jaundiced.

Kill distractors: Hepatocellular damage (A) would cause AST/ALT to dominate. Portal hypertension (C) does not cause this enzyme pattern acutely. Autoimmune hepatitis (D) is not related to tumor presence.

Board Lock: Elevated ALP + GGT out of proportion to AST/ALT = cholestatic pattern = biliary compression by mets.

Clue: Breast cancer is not a GI organ. It does not drain into the portal system.

Bridge: The portal vein is the GI highway. It collects blood from the intestines, stomach, and pancreas. Breast venous drainage goes into the axillary/subclavian veins, then superior vena cava, then right heart, then pulmonary circulation, then systemic arteries including the hepatic artery. So breast mets ride the arterial route.

Board Lock: Non-GI tumors (breast, lung, melanoma, renal) reach the liver via the hepatic artery, not the portal vein.

Clue: Multiple lesions, no cirrhosis, normal AFP, target sign on CT = classic mets presentation. The primary has not been found yet.

Bridge: Think of the liver as a strainer at the bottom of the body's drainage system. Cancer cells from any GI primary will hit it eventually. Sometimes the mets are found first, and then you work backward to find the hidden primary (most often colorectal).

Kill distractors: HCC requires cirrhosis or chronic hepatitis in the vast majority of cases, and AFP is typically elevated. Hemangiomas are benign and have a specific enhancement pattern (peripheral nodular). Abscesses are usually symptomatic with fever and leukocytosis.

Board Lock: Multiple liver lesions + no cirrhosis + normal AFP = mets from occult primary. Work up the GI tract (colonoscopy, CT chest/abdomen/pelvis).

Clue: "Cannon ball" = large, round, bilateral pulmonary nodules. This is one of the most tested visual patterns on boards.

Bridge: Renal cell carcinoma and thyroid CA are notorious for producing large, round, well-circumscribed pulmonary mets that look like cannon balls fired into the lungs. RCC is the more common boards answer. These tumors also produce vascular, hypervascular liver mets via the arterial route.

Board Lock: Cannon ball lung mets = Renal Cell Carcinoma (or thyroid). Not colon. Not pancreas.

Clue: Isolated (few) colorectal liver mets, no extrahepatic disease. This is the one scenario where surgery can be curative.

Bridge: Colorectal cancer is unique among GI cancers. If the mets are confined to the liver, technically resectable, and there is no spread elsewhere, hepatic resection can achieve long-term cure in 20-40% of cases. This is board-level knowledge.

Kill distractors: Hospice (A) is wrong because isolated resectable liver mets from colon CA are potentially curable. Chemo alone (B) is used for unresectable disease. Radiation (D) is not standard primary therapy for colorectal liver mets.

Board Lock: Isolated colon CA liver mets + no extrahepatic disease = surgical resection with curative intent. This is the ONLY cancer where liver met resection can be curative.

Clue: Unresectable colorectal mets to liver. What is the standard systemic backbone?

Bridge: 5-FU is the cornerstone of colorectal cancer therapy. Bevacizumab (anti-VEGF monoclonal antibody) is added to inhibit tumor angiogenesis, starving the mets of their blood supply. This combination (often as part of FOLFOX or FOLFIRI regimens) is the first-line standard for unresectable colorectal liver mets.

Kill distractors: Cisplatin/etoposide (A) is for small cell lung cancer. Gemcitabine/abraxane (B) is for pancreatic cancer. Carboplatin/paclitaxel (D) is for ovarian or lung cancer.

Board Lock: Unresectable colorectal liver mets = 5-FU + bevacizumab. The "5" is your anchor.

Clue: Cirrhosis + single liver mass + AFP markedly elevated. The clue triad is complete.

Bridge: HCC is the "home-grown" liver cancer. It almost always requires damaged soil (chronic hepatitis B or C, alcoholic cirrhosis, NASH). AFP above 400 in a cirrhotic patient is essentially diagnostic. Mets, by contrast, occur in non-cirrhotic livers and present with multiple lesions and normal AFP.

Board Lock: Cirrhosis + elevated AFP + liver mass = HCC. Mets = healthy liver + multiple lesions + normal AFP. Opposite scenarios. Memorize both.

Clue: Pancreatic cancer + liver first. Why liver before lungs?

Bridge: The pancreas drains into the portal venous system (splenic and superior mesenteric veins). That means tumor cells shed from the pancreas ride the portal vein directly into the hepatic sinusoids before ever entering the systemic circulation. The liver acts as the first capillary bed the cells encounter, and they get trapped there. The lungs only see the cells that escape the liver filter.

Board Lock: Pancreas drains portal → liver is the first capillary filter → liver mets before lung mets. This is the anatomical explanation for the portal rule.